
    
      The is an open-label study. Children diagnosed with ADHD will be provided with a weight-based
      dose of a chewable natural health product containing zinc, magnesium, vitamin B6 and vitamin
      C for 10 weeks with an additional follow-up post intervention at 20 weeks. Severity of ADHD
      symptoms will be measured at baseline, week 5 and week 10 using the Connor-3 Parent and
      SNAP-IV validated questionnaires. Nutritional status will be monitored at baseline and week
      10 for changes in serum zinc and erythrocyte magnesium. Children will be monitored for any
      adverse reactions that may occur using the investigational product.Following the informed
      consent process, participants will undergo a structured psychiatric interview prior to
      enrollment and will have 4 30 minute study visits and 2 10 minute telephone calls throughout
      the study. Blood samples will be taken 2 times with the use of a topical anesthetic to
      decrease sensation during the blood draw. Once enrolled, children can withdraw from the study
      at any time if assent to participate is withdrawn.
    
  